Deerfield Management Company, LP
Latest statistics and disclosures from DEERFIELD MANAGEMENT's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Avexis, Horizon Pharma, NXTM, Mylan Nv, Horizon Pharma Plc convertible security, and represent 23.62% of DEERFIELD MANAGEMENT's stock portfolio.
- Added to shares of these 10 stocks: GILD (+$81.71M), Kempharm Inc note 5.500% 2/0 (+$45.75M), Intercept Pharmas conv (+$39.52M), Flamel Technologies Sa (+$39.42M), MCK (+$33.95M), Horizon Pharma (+$29.38M), Isis Pharmaceuticals Inc Del note 1.000%11/1 (+$28.14M), Anaptysbio Inc Common (+$23.47M), Loxo Oncology (+$21.14M), VRX (+$16.55M).
- Started 20 new stock positions in MCK, Anaptysbio Inc Common, Jounce Therapeutics, Corvus Pharmaceuticals, Flamel Technologies Sa, Allscripts Healthcare So conv, Sage Therapeutics, Intercept Pharmas conv, DXCM, Sierra Oncology. GILD, Obalon Therapeutics, Kempharm Inc note 5.500% 2/0, Tivity Health, Acorda Therap note 1.75% 6/15, Tg Therapeutics, INFI, VRX, Syndax Pharmaceuticals, Impax Laboratories Inc conv.
- Reduced shares in these 10 stocks: Portola Pharmaceuticals (-$125.53M), Gw Pharmaceuticals Plc ads (-$60.79M), Aerie Pharmaceuticals (-$47.30M), FLML (-$42.32M), Nevro (-$32.64M), Array Biopharma Inc note 3.000% 6/0 (-$32.34M), HUM (-$26.55M), Wright Med Group Inc note 2.000% 2/1 (-$24.03M), Globus Med Inc cl a (-$21.56M), Healthways Inc note 1.500% 7/0 (-$20.64M).
- Sold out of its positions in Acura Pharmaceuticals, Catabasis Pharmaceuticals, CLDX, Clovis Oncology Inc note 2.500% 9/1, EXAS, FLML, Global Blood Therapeutics In, HWAY, Ionis Pharmaceuticals, KERX. Noveliontherapeutics, Ocera Therapeutics, Paratek Pharmaceuticals, Pronai Therapeutics, Proteostasis Therapeutics In, ZMH.
- DEERFIELD MANAGEMENT was a net seller of stock by $160.17M.
- DEERFIELD MANAGEMENT has $2.59B in assets under management (AUM), growing by 6.68%.
DEERFIELD MANAGEMENT portfolio companies for March 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Avexis | 6.56 | 2.24M | 76.03 | 0.00 |
| Horizon Pharma | 6.24 | 10.94M +22.00% | 14.78 | 0.00 |
| NxStage Medical (NXTM) | 3.88 | 3.74M -12.00% | 26.83 | 23.33 |
| Mylan Nv | 3.75 | 2.49M +12.00% | 38.99 | 0.00 |
| Horizon Pharma Plc convertible security | 3.20 | 90.10M +9.00% | 0.92 | 0.00 |
| Gilead Sciences (GILD) | 3.15 | 1.20M NEW | 67.92 | 70.52 |
| Dbv Technologies S A | 2.37 | 1.74M | 35.22 | 0.00 |
| Isis Pharmaceuticals Inc Del note 1.000%11/1 | 2.31 | 62.50M +88.00% | 0.96 | 0.00 |
| Portola Pharmaceuticals | 2.19 | 1.45M -68.00% | 39.19 | 0.00 |
| Blueprint Medicines | 2.11 | 1.36M -25.00% | 39.99 | 0.00 |
| Anthem | 2.03 | 318000 | 165.38 | 0.00 |
| Gw Pharmaceuticals Plc ads | 1.99 | 425545 -54.00% | 120.94 | 0.00 |
| Endologix Inc note 2.250%12/1 | 1.89 | 51.12M | 0.96 | 0.00 |
| Kempharm Inc note 5.500% 2/0 | 1.76 | 75.00M NEW | 0.61 | 0.00 |
| Centene Corporation (CNC) | 1.66 | 603643 | 71.26 | 84.15 |
| Lannett Company (LCI) | 1.60 | 1.85M -7.00% | 22.35 | 19.95 |
| Endologix, Inc. 3.25% 11/01/2020 | 1.55 | 40.50M | 0.99 | 0.00 |
| Intercept Pharmas conv | 1.52 | 42.50M NEW | 0.93 | 0.00 |
| Flamel Technologies Sa | 1.52 | 4.07M NEW | 9.68 | 0.00 |
| Trn 4% 04/01/45 | 1.50 | 48.00M | 0.81 | 0.00 |
| Editas Medicine | 1.47 | 1.71M | 22.32 | 0.00 |
| Nevro | 1.46 | 402998 -46.00% | 93.70 | 0.00 |
| Molina Healthcare Inc conv | 1.43 | 35.00M +40.00% | 1.06 | 0.00 |
| Aerie Pharmaceuticals | 1.39 | 795743 -56.00% | 45.35 | 0.00 |
| Aetna (AET) | 1.31 | 267000 +10.00% | 127.55 | 152.10 |
| McKesson Corporation (MCK) | 1.31 | 229000 NEW | 148.26 | 166.96 |
| Nevro Corp note 1.750% 6/0 | 1.30 | 27.60M | 1.22 | 0.00 |
| Mallinckrodt Pub | 1.25 | 728949 +79.00% | 44.57 | 0.00 |
| Vanda Pharmaceuticals (VNDA) | 1.24 | 2.30M -32.00% | 14.00 | 15.90 |
| eHealth (EHTH) | 1.23 | 2.64M | 12.04 | 18.25 |
| Array Biopharma Inc note 3.000% 6/0 | 1.23 | 22.39M -50.00% | 1.43 | 0.00 |
| Loxo Oncology | 1.22 | 753300 +200.00% | 42.08 | 0.00 |
| Xencor | 1.19 | 1.28M -36.00% | 23.92 | 0.00 |
| Walgreen Boots Alliance | 1.14 | 355957 | 83.05 | 0.00 |
| Universal American | 1.09 | 2.83M -24.00% | 9.97 | 0.00 |
| BioCryst Pharmaceuticals (BCRX) | 1.00 | 3.09M -4.00% | 8.40 | 6.12 |
| Ascendis Pharma A S | 1.00 | 929226 -11.00% | 28.00 | 0.00 |
| Syros Pharmaceuticals | 0.99 | 1.62M -10.00% | 15.93 | 0.00 |
| Epizyme | 0.94 | 1.41M -11.00% | 17.15 | 0.00 |
| Wright Med Group Inc note 2.000% 2/1 | 0.93 | 20.02M -50.00% | 1.20 | 0.00 |
| Audentes Therapeutics Inc Com stock | 0.92 | 1.40M | 17.04 | 0.00 |
| Anaptysbio Inc Common | 0.91 | 845746 NEW | 27.75 | 0.00 |
| Galapagos Nv-spon | 0.86 | 259768 -38.00% | 86.19 | 0.00 |
| Advanced Accelerat spon ads each rep 2 ord shs | 0.80 | 523023 +149.00% | 39.86 | 0.00 |
| Axogen | 0.74 | 1.84M | 10.45 | 0.00 |
| Fluidigm Corporation convertible cor | 0.72 | 27.71M | 0.67 | 0.00 |
| Recro Pharma | 0.70 | 2.08M | 8.74 | 0.00 |
| Healthways Inc note 1.500% 7/0 | 0.69 | 11.60M -53.00% | 1.54 | 0.00 |
| Aac Holdings | 0.65 | 1.98M | 8.53 | 0.00 |
| Valeant Pharmaceuticals Int (VRX) | 0.64 | 1.50M NEW | 11.03 | 15.80 |
| Cytomx Therapeutics | 0.63 | 943433 | 17.27 | 0.00 |
| Selecta Biosciences | 0.59 | 1.06M +24.00% | 14.32 | 0.00 |
| Spark Therapeutics | 0.58 | 283000 | 53.34 | 0.00 |
| Neos Therapeutics | 0.58 | 2.10M +816.00% | 7.20 | 0.00 |
| Humana (HUM) | 0.55 | 69185 -65.00% | 206.14 | 238.42 |
| Impax Laboratories Inc conv | 0.54 | 17.00M NEW | 0.82 | 0.00 |
| Invuity | 0.52 | 1.69M | 7.95 | 0.00 |
| Wave Life Sciences Ltd shs | 0.50 | 472124 | 27.50 | 0.00 |
| Akari Therapeutics | 0.49 | 1.15M | 11.07 | 0.00 |
| Aclaris Therapeutics | 0.43 | 375000 | 29.82 | 0.00 |
| Nivalis Therapeutics | 0.42 | 3.73M | 2.92 | 0.00 |
| Ardelyx | 0.41 | 841744 +125.00% | 12.65 | 0.00 |
| Jounce Therapeutics | 0.40 | 468867 NEW | 21.99 | 0.00 |
| Array BioPharma (ARRY) | 0.39 | 1.14M -30.00% | 8.94 | 9.07 |
| Tesaro | 0.39 | 66000 -41.00% | 153.86 | 0.00 |
| Steadymed Ltd shs | 0.39 | 1.76M | 5.80 | 0.00 |
| Bluebird Bio | 0.38 | 107064 -64.00% | 90.90 | 0.00 |
| Oxford Immunotec Global | 0.37 | 616508 +16.00% | 15.49 | 0.00 |
| Allscripts Healthcare So conv | 0.37 | 9.67M NEW | 1.00 | 0.00 |
| Dex (DXCM) | 0.36 | 110992 NEW | 84.73 | 77.33 |
| Glaukos | 0.36 | 180000 -54.00% | 51.30 | 0.00 |
| Globus Med Inc cl a | 0.35 | 308000 -70.00% | 29.62 | 0.00 |
| Sage Therapeutics | 0.33 | 122000 NEW | 71.07 | 0.00 |
| Axovant Sciences | 0.33 | 568005 | 14.94 | 0.00 |
| Alimera Sciences (ALIM) | 0.32 | 5.88M | 1.40 | 1.38 |
| Myovant Sciences | 0.32 | 705268 -52.00% | 11.74 | 0.00 |
| Tg Therapeutics | 0.31 | 700000 NEW | 11.65 | 0.00 |
| Sierra Oncology | 0.29 | 4.97M NEW | 1.53 | 0.00 |
| Nanostring Technologies | 0.27 | 352375 +153.00% | 19.87 | 0.00 |
| Essa Pharma | 0.26 | 2.12M | 3.12 | 0.00 |
| Infinity Pharmaceuticals (INFI) | 0.25 | 1.97M NEW | 3.23 | 1.81 |
| Kite Pharma | 0.25 | 81000 -72.00% | 78.49 | 0.00 |
| Myokardia | 0.22 | 424800 | 13.15 | 0.00 |
| Kempharm | 0.20 | 1.08M | 4.90 | 0.00 |
| Five Prime Therapeutics | 0.19 | 138000 | 36.15 | 0.00 |
| Sangamo Biosciences (SGMO) | 0.17 | 837963 | 5.20 | 9.30 |
| Acorda Therap note 1.75% 6/15 | 0.16 | 5.00M NEW | 0.85 | 0.00 |
| Foamix Pharmaceuticals Ltd shs | 0.16 | 817435 -33.00% | 4.95 | 0.00 |
| Ra Pharmaceuticals | 0.15 | 177830 -45.00% | 21.29 | 0.00 |
| Aralez Pharmaceuticals Inc Com stock | 0.14 | 1.64M | 2.14 | 0.00 |
| BioScrip (BIOS) | 0.13 | 1.97M | 1.70 | 2.68 |
| Agile Therapeutics | 0.12 | 971739 +144.00% | 3.20 | 0.00 |
| Genocea Biosciences | 0.11 | 479000 -30.00% | 6.09 | 0.00 |
| Adeptus Health Inc-class A | 0.11 | 1.60M | 1.80 | 0.00 |
| Scynexis | 0.11 | 1.05M | 2.76 | 0.00 |
| CAS Medical Systems (CASM) | 0.10 | 1.80M -43.00% | 1.45 | 1.10 |
| pSivida (PSDV) | 0.10 | 1.49M | 1.72 | 1.91 |
| Proteon Therapeutics | 0.09 | 1.33M | 1.75 | 0.00 |
| Tivity Health | 0.09 | 76000 NEW | 29.11 | 0.00 |
| Voyager Therapeutics | 0.06 | 117647 -50.00% | 13.24 | 0.00 |
| Threshold Pharmaceuticals (THLD) | 0.05 | 2.20M | 0.57 | 0.40 |
| Streamline Health Solutions (STRM) | 0.03 | 662971 | 1.02 | 1.00 |
| Corvus Pharmaceuticals | 0.03 | 36931 NEW | 20.77 | 0.00 |
| Syndax Pharmaceuticals | 0.02 | 38130 NEW | 13.72 | 0.00 |
| Obalon Therapeutics | 0.01 | 20953 NEW | 10.69 | 0.00 |
Download CSV 
Past 13F-HR SEC Filings for DEERFIELD MANAGEMENT
- DEERFIELD MANAGEMENT 2016 Q4 filed Feb. 14, 2017
- DEERFIELD MANAGEMENT 2016 Q3 filed Nov. 14, 2016
- DEERFIELD MANAGEMENT 2016 Q2 filed Aug. 15, 2016
- DEERFIELD MANAGEMENT 2016 Q1 filed May 16, 2016
- DEERFIELD MANAGEMENT 2015 Q4 filed Feb. 16, 2016
- DEERFIELD MANAGEMENT 2015 Q3 filed Nov. 16, 2015
- DEERFIELD MANAGEMENT 2015 Q1 filed May 15, 2015
- DEERFIELD MANAGEMENT 2014 Q4 filed Feb. 17, 2015
- DEERFIELD MANAGEMENT 2014 Q3 filed Nov. 14, 2014
- DEERFIELD MANAGEMENT 2014 Q2 filed Aug. 14, 2014
- DEERFIELD MANAGEMENT 2014 Q1 filed May 15, 2014
- DEERFIELD MANAGEMENT 2013 Q4 filed Feb. 14, 2014
- DEERFIELD MANAGEMENT 2013 Q3 filed Nov. 14, 2013
- DEERFIELD MANAGEMENT CO /NY 2013 Q2 filed Aug. 14, 2013
- Deerfield Management Company 2013 Q1 filed May 14, 2013
- Deerfield Management Company 2012 Q4 filed Feb. 14, 2013
- Deerfield Management Company 2012 Q3 filed Nov. 14, 2012
- Deerfield Management Company 2012 Q1 filed May 15, 2012
- Deerfield Management Company 2011 Q3 amended filed March 2, 2012